Association of Adiponectin with Components of Metabolic Syndrome in Western U
Suryakant Nagtilak
2019
View PDFchevron_right
Relationship between adiponectin & uric acid with inflammation in pathogenesis of metabolic syndrome
Suryakant Nagtilak
International Journal of Clinical Biochemistry and Research
View PDFchevron_right
Association of adiponectin leptin with insulin resistance in type-2 diabetes
Suryakant Nagtilak
International Journal of Clinical Biochemistry and Research, 2021
View PDFchevron_right
Adiponectin circulating levels and 10-year (2002–2012) cardiovascular disease incidence: the ATTICA Study
Constantine Tsigos
Endocrine
View PDFchevron_right
Fasting Adiponectin is Inversely Correlated with Metabolic Syndrome in Patients with Coronary Artery Disease
Chia Chi Lee
Internal Medicine, 2010
View PDFchevron_right
Serum Adiponectin and Coronary Heart Disease Risk in Older Black and White Americans
Alka Kanaya
The Journal of Clinical Endocrinology and Metabolism, 2006
View PDFchevron_right
Insulin effect on adipose tissue (AT) adiponectin expression is regulated by the insulin resistance status of the patients
Juan Lujan
Clinical Endocrinology, 2008
View PDFchevron_right
Plasma Levels of Adiponectin Are Associated With Insulin Resistance and Serum Levels of Triglyceride in Japanese Metabolically Obese, Normal-Weight Men With Normal Glucose Tolerance
Yoshio Sumida
Diabetes Care, 2003
View PDFchevron_right
Adiponectin, diabetes and ischemic heart failure: a challenging relationship
Francesco Orso
2012
View PDFchevron_right
Adiponectin plasma levels are increased by atorvastatin treatment in subjects at high cardiovascular risk
Jesus Egido
European Journal of Pharmacology, 2008
View PDFchevron_right
Association of Low Plasma Adiponectin With Early Diastolic Dysfunction
Samuel Dudley
Congestive Heart Failure, 2012
View PDFchevron_right
Peripheral Factors in the Metabolic Syndrome: The Pivotal Role of Adiponectin
achilles gravanis
Annals of the New York Academy of Sciences, 2006
View PDFchevron_right
Adiponectin concentrations as a criterion of metabolic control in persons with type 2 diabetes mellitus?
Josef Bartek
Biomedical Papers, 2003
View PDFchevron_right
Evaluation of Serum Adiponectin and Lipid Profile in Regular Hemodialysis Patients
Dr.Entedhar R . Sarhat
View PDFchevron_right
Adipose tissue as risk factor for kidney disease
Venera Berisha-Muharremi
IntechOpen eBooks, 2024
View PDFchevron_right
Circulating adiponectin levels and cardiovascular risk factors in acromegalic patients
Maura Arosio
European Journal of Endocrinology, 2004
View PDFchevron_right
Association of adiponectin with mortality in older adults: the Health, Aging, and Body Composition Study
Alka Kanaya
Diabetologia, 2009
View PDFchevron_right
Differential association of adiponectin with cardiovascular risk markers in men and women? The KORA survey 2000
Hans Hauner
International Journal of Obesity, 2006
View PDFchevron_right
Circulating Adiponectin: Associations with Risk Factors and the Reynolds Risk Score in Women without Prior Major Cardiovascular Events
Nicoleta Calomfirescu
Cardiology, 2010
View PDFchevron_right
Serum Adiponectin Levels and Mortality after Kidney Transplantation
Anna Rudas
Clinical Journal of the American Society of Nephrology, 2012
View PDFchevron_right
Adiponectin in chronic kidney disease is related more to metabolic disturbances than to decline in renal function
Aissa Aissa
View PDFchevron_right
Variations in adiponectin levels in patients with chronic kidney disease: a prospective study of 12 months
Claudia Velludo
Jornal Brasileiro de Nefrologia, 2012
View PDFchevron_right
Fasting serum adiponectin concentration is reduced in Indo-Asian subjects and is related to HDL cholesterol
Nasser Al-daghri
Diabetes, Obesity and Metabolism, 2003
View PDFchevron_right
To Evaluate the Association of Serum Adiponectin with Fasting and Postprandial Plasma Glucose and Fasting Lipids in Control, IGT and T2DM Subjects
Aliza Akter
Scholars journal of applied medical sciences, 2022
View PDFchevron_right
Adiponectin plasma levels decrease after surgery in pediatric patients with congenital heart disease
Silvia Ry
Clinical Biochemistry, 2012
View PDFchevron_right
Adiponectin and Mortality in Patients with Chronic Kidney Disease
Vandana Menon
Journal of the American Society of Nephrology, 2006
View PDFchevron_right
Mendelian Randomization Studies Do Not Support a Causal Role for Reduced Circulating Adiponectin Levels in Insulin Resistance and Type 2 Diabetes
Aurelian Bidulescu
Diabetes, 2013
View PDFchevron_right
Adiponectin levels in obese and non-obese middle-aged African–American women
Ping Patrick
Obesity Research & Clinical Practice, 2007
View PDFchevron_right
Circulating adiponectin and cardiovascular mortality in patients with type 2 diabetes mellitus: evidence of sexual dimorphism
Claudia Menzaghi
Cardiovascular Diabetology, 2014
View PDFchevron_right
Plasma adiponectin is related to the progression of kidney disease in type 2 diabetes patients
Gabriel Kacso
Scandinavian Journal of Clinical and Laboratory Investigation, 2012
View PDFchevron_right
Adiponectin and Insulin Resistance in Young and Healthy Smokers
Ramazan Ocal
Endocrine Journal, 2006
View PDFchevron_right
Adiponectin, metabolic risk factors, and cardiovascular events among patients with end-stage renal disease
F. Mallamaci
Journal of the American Society of Nephrology : JASN, 2002
View PDFchevron_right
The association of adiponectin serum level and ADIPOQ +45 T/G and ADIPOR1 −106 A/G gene polymorphisms with diabetic nephropathy in type 2 DM
manal kamal
Comparative Clinical Pathology, 2012
View PDFchevron_right
Plasma Adiponectin and Blood Pressure Progression in African Americans: The Jackson Heart Study
Aurelian Bidulescu
American Journal of Hypertension, 2021
View PDFchevron_right
To Study the Evidence of Linking Adipokines (Adiponectin, Leptin) with Metabolic Syndrome: A Systematic Review
Zaara Ahtasham
International journal of drug delivery technology, 2024
View PDFchevron_right